“The promise of biology is to do incredible things. Like cure different diseases, eliminate the organ waiting list, push life to other planets, or even begin to remediate our own planet.”
So says Danny Cabrera ENG’14, Co-founder of BioBots, a 3D printing company unlike any other, because they print in “biocompatible materials.” Danny explains: “think of these as different colored cartridges on your inkjet printer, only these are for tissues instead of printing in colors.”
That’s right, BioBots prints tissues that can mimic the human body, or pieces of it, and this is an incredibly powerful tool for researchers. “We’re seeing a lot of scientists who are using our devices to develop 3D tissue models for different disease models, or for different organ systems, things like liver, kidney, heart.” This allows these scientists to understand the function of these organs or systems better, and to model diseases, and their treatments, in ways far superior to current methods.
And this is just the beginning. Danny has a sweeping vision of all that biology can do. He’s convinced that biology is going to “become the engineering discipline of our generation, that we were going to be able to use biology to build all of the useful products that we’re used to, and also a lot of new products that we weren’t even aware of yet.” He sees BioBots as “the first tool in a whole new stack of tools that need to be built to transition—to take biology from being 2D into being 3D.”
Listen to Danny talk to Karl Ulrich about how the BioBots printer works (Karl makes sure he gets it in terms for the intelligent layperson), the current and future applications of an amazing tool like this—and some of the business aspects, like what an MVP looks like for an entirely new thing like BioBots, and how Danny figured out how to price it.